History | Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel | Guidance | NICE

History

A list of downloadable documents created during development.

Expected publication

Equality Impact Assessment (Guidance development) ^{PDF 84 KB} 25 May 2016

Final appraisal determination

Final appraisal determination
Final appraisal determination document ^{PDF 239 KB} 22 April 2016
Committee papers ^{PDF 606 KB} 22 April 2016

Appraisal consultation

Appraisal consultation
Appraisal consultation document ^{PDF 232 KB} 01 February 2016
Committee papers ^{PDF 4.72 MB} 01 February 2016

Invitation to participate

Equality impact assessment (Scoping) ^{PDF 78 KB} 23 December 2015

Draft scope documents

Draft scope (post-referral) ^{PDF 92 KB} 23 December 2015
Provisional matrix (post-referral) ^{PDF 90 KB} 23 December 2015

Appeal

Appeal
: Appeal letter ^{PDF 259 KB} 26 January 2012
: Scrutiny letter ^{PDF 254 KB} 03 February 2012
: Response to scrutiny letter ^{PDF 214 KB} 17 February 2012
: Final scrutiny letter ^{PDF 271 KB} 24 February 2012
Appeal decision ^{PDF 116 KB} 17 July 2012

Final appraisal determination

Final appraisal determination
Final appraisal determination document ^{PDF 192 KB} 14 December 2011
Committee papers ^{PDF 1.22 MB} 14 December 2011

Appraisal consultation: 1

Appraisal consultation: 1
Appraisal consultation document ^{PDF 263 KB} 23 September 2011
Committee papers ^{PDF 4.8 MB} 23 September 2011

Invitation to participate

Final scope ^{PDF 242 KB} 06 April 2011
Final matrix ^{PDF 299 KB} 24 March 2011

Prostate cancer (hormone relapsed, metastatic) - cabazitaxel (after docetaxel): final scope

Prostate cancer (hormone relapsed, metastatic) - cabazitaxel (after docetaxel): final scope ^{PDF 87 KB} 23 September 2015

Prostate cancer (hormone relapsed, metastatic) - cabazitaxel (after docetaxel): comments table

Prostate cancer (hormone relapsed, metastatic) - cabazitaxel (after docetaxel): comments table ^{PDF 140 KB} 23 September 2015

Prostate cancer (hormone relapsed, metastatic) - cabazitaxel (after docetaxel): final matrix

Prostate cancer (hormone relapsed, metastatic) - cabazitaxel (after docetaxel): final matrix ^{PDF 91 KB} 23 September 2015